LRIG1 and glioblastoma: Interestingly, Lrig1 has been found to enhance sensitivity to cytotoxic drugs, reverse multidrug resistance, and enhance radiosensitivity of serum-cultured U251 GBM cells via EGFR repression (Wang et al., 2012; Liu et al., 2015; Yang et al., 2015).